Press release centre
Past Press Releases - Galantos Pharma
September 9, 2013
Neurodyn Inc. acquires Memogain for Dementia in Alzheimer’s Disease
Neurodyn Inc. and Galantos Pharma GmbH announced today that Neurodyn has acquired from Galantos Pharma GmbH, Mainz, Germany (galantos.com) all assets related to their Alzheimer’s prescription drug candidate – Memogain®. More
July 6, 2009
Galantos Pharma receives government grant for the development of novel drugs against Alzheimer
Public funding by BMBF speeds up Company’s ambitious preclinical program. More
May 28, 2008
Galantos Pharma receives research grant
Galantos Pharma GmbH, a biopharmaceutical company developing natural product derivatives to treat Alzheimer’s disease (AD) today announced that it has been granted EUR 366.000 from Investitions- und Strukturbank Rheinland-Pfalz (ISB) GmbH, More | | Data
27,871
Tech investments
From our Online Data Service
|
17,963
VC-backed companies
From our Radar
|
Recent Deals
For information on Europe's most extensive database on technology funding click here!
|  |
Events
Press Releases
|
